Dan Jarvis is a U.S. Army combat Infantryman, former Deputy Sheriff, and founder of Healing the Hero, a nonprofit Christian ministry devoted to ending the cycle of trauma and suicide among active duty, veterans, first responders, Gold Star families and immediate family members.
Born into a Navy family, Dan’s life of service started early and spanned two wars. He led combat missions in Iraq and Afghanistan as an Infantry Squad Leader, earning a Bronze Star Medal and Purple Heart. Between deployments to Iraq and Afghanistan he served as a U.S. Army Drill Sergeant, he shaped civilians into Soldiers. Yet Dan’s fiercest battle came after the uniform came off — confronting PTSD, survivor’s guilt, and depression that nearly claimed his life on March 2, 2013.
Frustrated with conventional therapies that failed many warriors, Dan founded 22ZERO with his ex-wife Dr. Gwinnell Brant in April 2018, where he developed the Trauma Resiliency Protocol (TRP) and Emotions Management Process (EMP) — pioneering methods designed to neutralize trauma without reliving it. These breakthroughs have helped thousands reclaim their lives. These methods are now patent pending. Dan resigned from 22ZERO in 2023.
In 2024, Dan launched Healing the Hero to continue this mission, combining peer-driven support with faith-integrated healing through his latest innovation — the Trauma Resiliency Protocol–Peer Rescue (TRP-PR) and the Jesus Protocol. These 9-line protocols diffuse trauma triggers and negative emotions in minutes and are now being scientifically validated through qEEG brain scans and heart rate variability research at Arizona State University with first responders, veterans and active-duty military.
Through his leadership, Healing the Hero is shaping national initiatives, including an upcoming study on corrections officers at the Cook County Jail — the largest and one of the most challenging correctional facilities in America — aiming to reverse the devastating mental health crisis among law enforcement. San Diego State University will publish this study with an Institutional Review Board with Dr. Trejbalova as the primary investigator.